A study has shown that a relatively high ratio of CD4 + tumor-infiltrating lymphocytes to CD8 + tumor-infiltrating lymphocytes was observed around GBM, which was proved to be a signal of poorer overall survival [44, 48]. The gene discussed is CD8A; the disease is glioblastoma.